Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antioxidants & cancer

This article was originally published in The Tan Sheet

Executive Summary

Participants taking "a combination of selenium, beta-carotene and vitamin E supplements had significantly lower cancer mortality rates than those who did not receive the supplements," Philip Taylor, National Cancer Institute, et al., report in Sept. 17 issue of the Journal of the National Cancer Institute. The General Population Trial in Linxian, China, involved 29,584 stratified participants with an "extraordinarily high" incidence of esophageal and gastric cardia and non-cardia cancers. Researchers found no link between serum beta-carotene levels and cancer risk. "Our findings suggest that alpha-tocopherol and selenium are more likely than beta-carotene to be involved in the reduced cancer rates observed with supplementation during the trial," Taylor et al. conclude...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel